Using a recently developed PTDSS1 inhibitor, we screened 47 cancer cell lines for survivability under the restriction of PS synthesis and identified B cell lymphoma as a highly PS-dependent cancer type. The gene discussed is PTDSS1; the disease is B-cell non-Hodgkin lymphoma.